Table of Content


Chapter 1. Global Nanomedicine Market Executive Summary
1.1. Global Nanomedicine Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Application
1.3.2. By Indication
1.3.3. By Molecule Type
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Nanomedicine Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Nanomedicine Market Dynamics
3.1. Market Drivers
3.1.1. Rising Burden of Oncology and Infectious Diseases
3.1.2. Demand for Targeted and Controlled Drug Delivery
3.1.3. Integration of AI/ML in Nano-therapeutic Development
3.2. Market Challenges
3.2.1. High R&D and Manufacturing Costs
3.2.2. Complex Regulatory and Safety Concerns
3.2.3. Lack of Standardization in Nanoformulation Protocols
3.3. Market Opportunities
3.3.1. Expansion in Emerging and Medical Tourism Markets
3.3.2. Innovations in Smart Nanocarrier Platforms
3.3.3. New Indications in Wound Healing and Diagnostics
Chapter 4. Global Nanomedicine Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Nanomedicine Market Size & Forecasts by Application 2022-2032
5.1. Segment Dashboard
5.2. Global Nanomedicine Market: Drug Delivery Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
Chapter 6. Global Nanomedicine Market Size & Forecasts by Indication 2022-2032
6.1. Segment Dashboard
6.2. Global Nanomedicine Market: Indication Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
6.2.1. Clinical Oncology
6.2.2. Infectious Diseases
Chapter 7. Global Nanomedicine Market Size & Forecasts by Region 2022-2032
7.1. North America Nanomedicine Market
7.1.1. U.S. Nanomedicine Market
7.1.1.1. Application breakdown size & forecasts, 2022-2032
7.1.1.2. Indication breakdown size & forecasts, 2022-2032
7.1.2. Canada Nanomedicine Market
7.2. Europe Nanomedicine Market
7.2.1. UK Nanomedicine Market
7.2.2. Germany Nanomedicine Market
7.2.3. France Nanomedicine Market
7.2.4. Spain Nanomedicine Market
7.2.5. Italy Nanomedicine Market
7.2.6. Rest of Europe Nanomedicine Market
7.3. Asia-Pacific Nanomedicine Market
7.3.1. China Nanomedicine Market
7.3.2. India Nanomedicine Market
7.3.3. Japan Nanomedicine Market
7.3.4. Australia Nanomedicine Market
7.3.5. South Korea Nanomedicine Market
7.3.6. Rest of Asia Pacific Nanomedicine Market
7.4. Latin America Nanomedicine Market
7.4.1. Brazil Nanomedicine Market
7.4.2. Mexico Nanomedicine Market
7.4.3. Rest of Latin America Nanomedicine Market
7.5. Middle East & Africa Nanomedicine Market
7.5.1. Saudi Arabia Nanomedicine Market
7.5.2. South Africa Nanomedicine Market
7.5.3. Rest of Middle East & Africa Nanomedicine Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Johnson & Johnson
8.1.2. Pfizer Inc.
8.1.3. Abbott Laboratories
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Johnson & Johnson
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Pfizer Inc.
8.3.3. Abbott Laboratories
8.3.4. Merck & Co., Inc.
8.3.5. Celgene Corporation
8.3.6. Sanofi S.A.
8.3.7. Teva Pharmaceutical Industries Ltd.
8.3.8. Amgen Inc.
8.3.9. Gilead Sciences, Inc.
8.3.10. Bayer AG
8.3.11. GE Healthcare
8.3.12. Novartis AG
8.3.13. Roche Holding AG
8.3.14. GlaxoSmithKline plc
8.3.15. Bausch Health Companies Inc.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes



List of Figures

List of Figures
FIG 1. Global Nanomedicine market, research methodology
FIG 2. Global Nanomedicine market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Nanomedicine market, key trends 2023
FIG 5. Global Nanomedicine market, growth prospects 2022-2032
FIG 6. Global Nanomedicine market, Porter’s 5 force model
FIG 7. Global Nanomedicine market, PESTEL analysis
FIG 8. Global Nanomedicine market, value chain analysis
FIG 9. Global Nanomedicine market by segment, 2022 & 2032 (USD Million/Billion)
FIG 10. Global Nanomedicine market by segment, 2022 & 2032 (USD Million/Billion)
FIG 11. Global Nanomedicine market by segment, 2022 & 2032 (USD Million/Billion)
FIG 12. Global Nanomedicine market by segment, 2022 & 2032 (USD Million/Billion)
FIG 13. Global Nanomedicine market by segment, 2022 & 2032 (USD Million/Billion)
FIG 14. Global Nanomedicine market, regional snapshot 2022 & 2032
FIG 15. North America Nanomedicine market 2022 & 2032 (USD Million/Billion)
FIG 16. Europe Nanomedicine market 2022 & 2032 (USD Million/Billion)
FIG 17. Asia Pacific Nanomedicine market 2022 & 2032 (USD Million/Billion)
FIG 18. Latin America Nanomedicine market 2022 & 2032 (USD Million/Billion)
FIG 19. Middle East & Africa Nanomedicine market 2022 & 2032 (USD Million/Billion)
FIG 20. Global Nanomedicine market, company market share analysis (2023)

List of Tables

List of Tables
TABLE 1. Global Nanomedicine market, report scope
TABLE 2. Global Nanomedicine market estimates & forecasts by Region 2022-2032 (USD Million/Billion)
TABLE 3. Global Nanomedicine market estimates & forecasts by Application 2022-2032 (USD Million/Billion)
TABLE 4. Global Nanomedicine market estimates & forecasts by Indication 2022-2032 (USD Million/Billion)
TABLE 5. Global Nanomedicine market by segment, estimates & forecasts, 2022-2032 (USD Million/Billion)
TABLE 6. Global Nanomedicine market by region, estimates & forecasts, 2022-2032 (USD Million/Billion)
TABLE 7. Global Nanomedicine market by segment, estimates & forecasts, 2022-2032 (USD Million/Billion)
TABLE 8. Global Nanomedicine market by region, estimates & forecasts, 2022-2032 (USD Million/Billion)
TABLE 9. Global Nanomedicine market by segment, estimates & forecasts, 2022-2032 (USD Million/Billion)
TABLE 10. Global Nanomedicine market by region, estimates & forecasts, 2022-2032 (USD Million/Billion)
TABLE 11. Global Nanomedicine market by segment, estimates & forecasts, 2022-2032 (USD Million/Billion)
TABLE 12. Global Nanomedicine market by region, estimates & forecasts, 2022-2032 (USD Million/Billion)
TABLE 13. Global Nanomedicine market by segment, estimates & forecasts, 2022-2032 (USD Million/Billion)
TABLE 14. Global Nanomedicine market by region, estimates & forecasts, 2022-2032 (USD Million/Billion)
TABLE 15. U.S. Nanomedicine market estimates & forecasts, 2022-2032 (USD Million/Billion)
TABLE 16. U.S. Nanomedicine market estimates & forecasts by Application 2022-2032 (USD Million/Billion)
TABLE 17. U.S. Nanomedicine market estimates & forecasts by Indication 2022-2032 (USD Million/Billion)
TABLE 18. Canada Nanomedicine market estimates & forecasts, 2022-2032 (USD Million/Billion)
TABLE 19. Canada Nanomedicine market estimates & forecasts by Application 2022-2032 (USD Million/Billion)
TABLE 20. Canada Nanomedicine market estimates & forecasts by Indication 2022-2032 (USD Million/Billion)